BKM120 + mFOLFOX6 in Advanced Solid Tumors With Expansion Cohort Pancreatic Cancer
Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to establish the safety and tolerability of BKM120 when combined
with mFOLFOX6 and to define the maximum tolerated dose of BKM120 in this combination in
advanced solid tumors including metastatic pancreatic cancer.